WS01.3 A †̃surprisingâ€TM pair: the synergistic antimicrobial activity of polymyxin B in combination with the cystic fibrosis drug ivacaftor against polymyxin-resistant P. aeruginosa

WS01.1 Discontinuation of routine anti-staphylococcal prophylaxis has no adverse effect on a paediatric CF patient population A. Shawcross, J. Holman, A. Maitra, A. Horsley, L.B. Patel, J. Panickar. Royal Manchester Childrens Hospital, Department of Paediatric Respiratory Medicine, Manchester, United Kingdom; University of Manchester, Institute of Inflammation and Repair, University Hospital of South Manchester, Wythenshawe, Manchester, United Kingdom; Manchester Adult Cystic Fibrosis Centre, University Hospital of South Manchester, Wythenshawe, Manchester, United Kingdom; SKMC Hospital, Department of Paediatric Respiratory Medicine, Abu Dhabi, United Arab Emirates